-
1
-
-
33847629709
-
Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease
-
Tolman KG, Fonseca V, Dalpiaz A, Tan MH. Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diab Care 2007; 30: 734-43.
-
(2007)
Diab Care
, vol.30
, pp. 734-743
-
-
Tolman, K.G.1
Fonseca, V.2
Dalpiaz, A.3
Tan, M.H.4
-
2
-
-
33746058666
-
Diabetes in chronic liver disease: From old concepts to new evidence
-
Picardi A, D'Avola D, Gentilucci UV, Galati G, Fiori E, Spataro S, Afeltra A. Diabetes in chronic liver disease: from old concepts to new evidence. Diabetes Metab Res Rev 2006; 22: 274-83.
-
(2006)
Diabetes Metab Res Rev
, vol.22
, pp. 274-283
-
-
Picardi, A.1
D'Avola, D.2
Gentilucci, U.V.3
Galati, G.4
Fiori, E.5
Spataro, S.6
Afeltra, A.7
-
3
-
-
34548860072
-
Impact of diabetes on the severity of liver disease
-
Hickman IJ, Macdonald GA. Impact of diabetes on the severity of liver disease. Am J Med 2007; 120: 829-34.
-
(2007)
Am J Med
, vol.120
, pp. 829-834
-
-
Hickman, I.J.1
Macdonald, G.A.2
-
4
-
-
84856891931
-
The prevalence and clinical characteristics of glucose metabolism disorders in patients with liver cirrhosis. A prospective study
-
García-Compeán D, Jáquez-Quintana JO, Lavalle-González FJ, Reyes-Cabello E, González-González JA, Muñoz-Espinosa LE, Vázquez-Elizondo G, et al. The prevalence and clinical characteristics of glucose metabolism disorders in patients with liver cirrhosis. A prospective study. Ann Hepatol 2012; 11: 240-8.
-
(2012)
Ann Hepatol
, vol.11
, pp. 240-248
-
-
García-Compeán, D.1
Jáquez-Quintana, J.O.2
Lavalle-González, F.J.3
Reyes-Cabello, E.4
González-González, J.A.5
Muñoz-Espinosa, L.E.6
Vázquez-Elizondo, G.7
-
5
-
-
0036019526
-
Clinical implications of hepatogenous diabetes in liver cirrhosis
-
Holstein A, Hinze S, Thiessen E, Plaschke A, Egberts EH. Clinical implications of hepatogenous diabetes in liver cirrhosis. J Gastroenterol Hepatol 2002; 17: 677-81.
-
(2002)
J Gastroenterol Hepatol
, vol.17
, pp. 677-681
-
-
Holstein, A.1
Hinze, S.2
Thiessen, E.3
Plaschke, A.4
Egberts, E.H.5
-
6
-
-
0028365236
-
Prognostic significance of diabetes in patients with cirrhosis
-
Bianchi G, Marchesini G, Zoli M, Bugianesi E, Fabbri A, Pisi E. Prognostic significance of diabetes in patients with cirrhosis. Hepatology 1994; 20: 119-25.
-
(1994)
Hepatology
, vol.20
, pp. 119-125
-
-
Bianchi, G.1
Marchesini, G.2
Zoli, M.3
Bugianesi, E.4
Fabbri, A.5
Pisi, E.6
-
7
-
-
33644871802
-
Oral glucose tolerance test predicts prognosis of patients with liver cirrhosis
-
Nishida T, Tsuji S, Tsujii M, Arimitsu S, Haruna Y, Imano E, Suzuki M, et al. Oral glucose tolerance test predicts prognosis of patients with liver cirrhosis. Am J Gastroenterol 2006; 101: 70-5.
-
(2006)
Am J Gastroenterol
, vol.101
, pp. 70-75
-
-
Nishida, T.1
Tsuji, S.2
Tsujii, M.3
Arimitsu, S.4
Haruna, Y.5
Imano, E.6
Suzuki, M.7
-
8
-
-
79956054217
-
The impact of diabetes mellitus in mortality of patients with compensated liver cirrhosis-a prospective study
-
Jáquez-Quintana JO, García-Compean, González-González JA, Villarreal Pérez JZ, Lavalle González FJ, Muñoz Espinosa LE, López-Hernández P, et al. The impact of diabetes mellitus in mortality of patients with compensated liver cirrhosis-a prospective study. Ann Hepatol 2011; 10: 56-62.
-
(2011)
Ann Hepatol
, vol.10
, pp. 56-62
-
-
Jáquez-Quintana, J.O.1
García-Compean, G.-G.J.A.2
Villarreal Pérez, J.Z.3
Lavalle González, F.J.4
Muñoz Espinosa, L.E.5
López-Hernández, P.6
-
9
-
-
59249096920
-
Liver cirrhosis and diabetes: Risk factors, pathophysiology, clinical implications and management
-
Garcia-Compean D, Jaquez-Quintana JO, Gonzalez-Gonzalez JA, Maldonado-Garza H. Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management. World J Gastroenterol 2009; 21: 280-8.
-
(2009)
World J Gastroenterol
, vol.21
, pp. 280-288
-
-
Garcia-Compean, D.1
Jaquez-Quintana, J.O.2
Gonzalez-Gonzalez, J.A.3
Maldonado-Garza, H.4
-
10
-
-
27644510019
-
Review article: Type 2 diabetes and chronic liver disease in the Verona diabetes study
-
Trombetta M, Spiazzi G, Zoppini G, Muggeo M. Review article: type 2 diabetes and chronic liver disease in the Verona diabetes study. Aliment Pharmacol Ther 2005; 22: 24-7.
-
(2005)
Aliment Pharmacol Ther
, vol.22
, pp. 24-27
-
-
Trombetta, M.1
Spiazzi, G.2
Zoppini, G.3
Muggeo, M.4
-
11
-
-
33845389796
-
Association between liver fibrosis and insulin sensitivity in chronic hepatitis C patients
-
Taura N, Ichikawa T, Hamasaki K, Nakao K, Nishimura D, Goto T, Fukuta, et al. Association between liver fibrosis and insulin sensitivity in chronic hepatitis C patients. Am J Gastroenterol 2006; 101: 2752-9.
-
(2006)
Am J Gastroenterol
, vol.101
, pp. 2752-2759
-
-
Taura, N.1
Ichikawa, T.2
Hamasaki, K.3
Nakao, K.4
Nishimura, D.5
Goto, T.F.6
-
12
-
-
70349238777
-
Adipokines in the liver disease
-
Marra F, Bertolani C. Adipokines in the liver disease. Hepatology 2009; 50: 957-69.
-
(2009)
Hepatology
, vol.50
, pp. 957-969
-
-
Marra, F.1
Bertolani, C.2
-
13
-
-
0030982229
-
TGF-betamediated hepatocellular apoptosis by rat and human hepatoma cells and primary rat hepatocytes
-
Gressner AM, Lahme B, Mannherz HG, Polzar B. TGF-betamediated hepatocellular apoptosis by rat and human hepatoma cells and primary rat hepatocytes. J Hepatol 1997; 26: 1079-92.
-
(1997)
J Hepatol
, vol.26
, pp. 1079-1092
-
-
Gressner, A.M.1
Lahme, B.2
Mannherz, H.G.3
Polzar, B.4
-
14
-
-
54949128696
-
Fibrosis and cirrhosis reversibility-molecular mechanisms
-
Gieling RG, Burt Ad, Mann DA. Fibrosis and cirrhosis reversibility-molecular mechanisms. Clin Liver Dis 2008; 12: 915-37.
-
(2008)
Clin Liver Dis
, vol.12
, pp. 915-937
-
-
Gieling, R.G.1
Burt, A.2
Mann, D.A.3
-
15
-
-
4444220877
-
Soluble TNF-R1, but not tumor necrosis factor alpha, predicts the 3-month mortality in patients with alcoholic hepatitis
-
Spahr L, Giostra E, Frossard JL, Bresson-Hadni S, Rubbia-Brandt L, Hadengue A. Soluble TNF-R1, but not tumor necrosis factor alpha, predicts the 3-month mortality in patients with alcoholic hepatitis. J Hepatol 2004; 41: 229-34.
-
(2004)
J Hepatol
, vol.41
, pp. 229-234
-
-
Spahr, L.1
Giostra, E.2
Frossard, J.L.3
Bresson-Hadni, S.4
Rubbia-Brandt, L.5
Hadengue, A.6
-
16
-
-
0028277663
-
Unraveling function in the TNF ligand and receptor families
-
Beutler B, van Huffel C. Unraveling function in the TNF ligand and receptor families. Science 1994; 264: 667-8.
-
(1994)
Science
, vol.264
, pp. 667-668
-
-
Beutler, B.1
van Huffel, C.2
-
17
-
-
0028895940
-
Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release
-
Leist M, Gantner F, Jilg S, Wendel A. Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J Immunol 1995; 154: 1307-16.
-
(1995)
J Immunol
, vol.154
, pp. 1307-1316
-
-
Leist, M.1
Gantner, F.2
Jilg, S.3
Wendel, A.4
-
18
-
-
0025363385
-
Increased plasma tumor necrosis factor in severe alcoholic hepatitis
-
Bird GL, Sheron N, Goka AK, Alexander GJ, Williams RS. Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med 1990; 112: 917-20.
-
(1990)
Ann Intern Med
, vol.112
, pp. 917-920
-
-
Bird, G.L.1
Sheron, N.2
Goka, A.K.3
Alexander, G.J.4
Williams, R.S.5
-
19
-
-
33845388354
-
Insulin resistance and hepatitis C
-
Romero-Gómez M. Insulin resistance and hepatitis C. World J Gastroenterol 2006; 12: 7075-80.
-
(2006)
World J Gastroenterol
, vol.12
, pp. 7075-7080
-
-
Romero-Gómez, M.1
-
20
-
-
0036022846
-
Leptin is essential for the hepatic fibrogenic response to chronic liver injury
-
Leclercq IA, Farrell GC, Schriemer R, Robertson GR. Leptin is essential for the hepatic fibrogenic response to chronic liver injury. J Hepatol 2002; 37: 206-13.
-
(2002)
J Hepatol
, vol.37
, pp. 206-213
-
-
Leclercq, I.A.1
Farrell, G.C.2
Schriemer, R.3
Robertson, G.R.4
-
21
-
-
0036234147
-
Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat
-
Ikejima K, Takei Y, Honda H, Hirose M, Yoshikawa M, Zhang YJ, Lang T, et al. Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat. Gastroenterology 2002; 122: 1399-410.
-
(2002)
Gastroenterology
, vol.122
, pp. 1399-1410
-
-
Ikejima, K.1
Takei, Y.2
Honda, H.3
Hirose, M.4
Yoshikawa, M.5
Zhang, Y.J.6
Lang, T.7
-
22
-
-
0034927064
-
Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals
-
Ikejima K, Honda H, Yoshikawa M, Hirose M, Kitamura T, Takei Y, Sato N, et al. Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals. Hepatology 2001; 34: 288-97.
-
(2001)
Hepatology
, vol.34
, pp. 288-297
-
-
Ikejima, K.1
Honda, H.2
Yoshikawa, M.3
Hirose, M.4
Kitamura, T.5
Takei, Y.6
Sato, N.7
-
23
-
-
0036204924
-
Leptin in hepatic fibrosis: Evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice
-
Saxena NK, Ikeda K, Rockey DC, Friedman SL, Anania FA. Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice. Hepatology 2002; 35: 762-71.
-
(2002)
Hepatology
, vol.35
, pp. 762-771
-
-
Saxena, N.K.1
Ikeda, K.2
Rockey, D.C.3
Friedman, S.L.4
Anania, F.A.5
-
24
-
-
0026741275
-
Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo
-
Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci USA 1992; 89: 4845-9.
-
(1992)
Proc Natl Acad Sci USA
, vol.89
, pp. 4845-4849
-
-
Van Zee, K.J.1
Kohno, T.2
Fischer, E.3
Rock, C.S.4
Moldawer, L.L.5
Lowry, S.F.6
-
25
-
-
58149327042
-
Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: Is it really benign?
-
Tarantino G, Conca P, Riccio A, Tarantino M, Di Minno MN, Chianese D, Pasanisi F, et al. Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign? J Transl Med 2008; 6: 72-8.
-
(2008)
J Transl Med
, vol.6
, pp. 72-78
-
-
Tarantino, G.1
Conca, P.2
Riccio, A.3
Tarantino, M.4
Di Minno, M.N.5
Chianese, D.6
Pasanisi, F.7
-
26
-
-
0034799895
-
Plasma transforming growth factor-beta 1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: A pilot study
-
Hasegawa T, Yoneda M, Nakamura K, Makino I, Terano A. Plasma transforming growth factor-beta 1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study. Aliment PharmacolTher 2001; 15: 1667-72.
-
(2001)
Aliment PharmacolTher
, vol.15
, pp. 1667-1672
-
-
Hasegawa, T.1
Yoneda, M.2
Nakamura, K.3
Makino, I.4
Terano, A.5
-
27
-
-
78651276631
-
Diagnosis and classification of diabetes mellitus
-
American Diabetes Association
-
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diab Care 2011; 34(Suppl. 1): S62-S69.
-
(2011)
Diab Care
, vol.34
, Issue.SUPPL. 1
-
-
-
29
-
-
0015854966
-
Transection of the oesophagus for bleeding oesophagealvarices
-
Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophagealvarices. Br J Surg 1973; 60: 646-9.
-
(1973)
Br J Surg
, vol.60
, pp. 646-649
-
-
Pugh, R.N.1
Murray-Lyon, I.M.2
Dawson, J.L.3
Pietroni, M.C.4
Williams, R.5
-
30
-
-
33947428441
-
The Model for End-Stage Liver Disease (MELD)
-
Kamath PS, Ray Kim W. The Model for End-Stage Liver Disease (MELD). Hepatology 2007; 45: 797-805.
-
(2007)
Hepatology
, vol.45
, pp. 797-805
-
-
Kamath, P.S.1
Ray Kim, W.2
-
32
-
-
0025162106
-
Alterations of glucose metabolism in chronic liver disease
-
Del Vecchio Blanco C, Gentile S, Marmo R, Carbone L, Coltorti M. Alterations of glucose metabolism in chronic liver disease. Diabetes Res Clin Pract 1990; 8: 29-36.
-
(1990)
Diabetes Res Clin Pract
, vol.8
, pp. 29-36
-
-
Del Vecchio Blanco, C.1
Gentile, S.2
Marmo, R.3
Carbone, L.4
Coltorti, M.5
-
33
-
-
0026737258
-
Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia
-
Spinas GA, Keller U, Brockhaus M. Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia. J Clin Invest 1992; 90: 533-6.
-
(1992)
J Clin Invest
, vol.90
, pp. 533-536
-
-
Spinas, G.A.1
Keller, U.2
Brockhaus, M.3
-
34
-
-
0027320959
-
Tumor necrosis factor alpha and interleukin 6 plasma levels in infected cirrhotic patients
-
Byl B, Roucloux I, Crusiaux A, Dupont E, Devière J. Tumor necrosis factor alpha and interleukin 6 plasma levels in infected cirrhotic patients. Gastroenterology 1993; 104: 1492-7.
-
(1993)
Gastroenterology
, vol.104
, pp. 1492-1497
-
-
Byl, B.1
Roucloux, I.2
Crusiaux, A.3
Dupont, E.4
Devière, J.5
-
35
-
-
0033947017
-
Circulating transforming growth factor beta (1) as an indicator of hepatic function impairment in liver cirrhosis
-
Flisiak R, Pytel-Krolczuk B, Prokopowicz D. Circulating transforming growth factor beta (1) as an indicator of hepatic function impairment in liver cirrhosis. Cytokine 2000; 12: 677-81.
-
(2000)
Cytokine
, vol.12
, pp. 677-681
-
-
Flisiak, R.1
Pytel-Krolczuk, B.2
Prokopowicz, D.3
-
36
-
-
85067752061
-
Serum TGF-M-1 levels in non-alcoholic steatohepatitis
-
Yener S, Akinci B, Bayraktar F, Demir T, Akarsu M, Özcan MA, Yalcin M, et al. Serum TGF-M-1 levels in non-alcoholic steatohepatitis. Endocrine Abstracts 2006; 11: 231.
-
(2006)
Endocrine Abstracts
, vol.11
, pp. 231
-
-
Yener, S.1
Akinci, B.2
Bayraktar, F.3
Demir, T.4
Akarsu, M.5
Özcan, M.A.6
Yalcin, M.7
-
38
-
-
33746360865
-
Serum leptin in patients with alcoholic liver disease
-
Naveau S, Perlemuter G, Chaillet M, Raynard B, Balian A, Beuzen F, Portier A, et al. Serum leptin in patients with alcoholic liver disease. Alcohol Clin Exp Res 2006; 30: 1422-8.
-
(2006)
Alcohol Clin Exp Res
, vol.30
, pp. 1422-1428
-
-
Naveau, S.1
Perlemuter, G.2
Chaillet, M.3
Raynard, B.4
Balian, A.5
Beuzen, F.6
Portier, A.7
-
39
-
-
0033935111
-
Serum leptin levels in posthepatitis liver cirrhosis
-
Greco AV, Mingrone G, Favuzzi A, Capristo E, Gniuli D, Addolorato G, Brunani A, et al. Serum leptin levels in posthepatitis liver cirrhosis. J Hepatol 2000; 33: 38-42.
-
(2000)
J Hepatol
, vol.33
, pp. 38-42
-
-
Greco, A.V.1
Mingrone, G.2
Favuzzi, A.3
Capristo, E.4
Gniuli, D.5
Addolorato, G.6
Brunani, A.7
-
40
-
-
70349238777
-
Adipokines in liver diseases
-
Marra F, Bertolani C. Adipokines in liver diseases. Hepatology 2009; 50: 957-69.
-
(2009)
Hepatology
, vol.50
, pp. 957-969
-
-
Marra, F.1
Bertolani, C.2
-
41
-
-
34248589442
-
Distinct roles of free leptin, bound leptin and soluble leptin receptor during the metabolic-inflammatory response in patients with liver cirrhosis
-
Ockenga J, Tietge UJ, Böker KH, Manns MP, Brabant G, Bahr MJ. Distinct roles of free leptin, bound leptin and soluble leptin receptor during the metabolic-inflammatory response in patients with liver cirrhosis. Aliment Pharmacol Ther 2007; 25: 1301-9.
-
(2007)
Aliment Pharmacol Ther
, vol.25
, pp. 1301-1309
-
-
Ockenga, J.1
Tietge, U.J.2
Böker, K.H.3
Manns, M.P.4
Brabant, G.5
Bahr, M.J.6
-
42
-
-
0029817895
-
Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats
-
Yasuda H, Imai E, Shiota A, Fujise N, Morinaga T, Higashio K. Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats. Hepatology 1996; 24: 636-42.
-
(1996)
Hepatology
, vol.24
, pp. 636-642
-
-
Yasuda, H.1
Imai, E.2
Shiota, A.3
Fujise, N.4
Morinaga, T.5
Higashio, K.6
-
43
-
-
77957948638
-
Hepatocyte growth factor and chronic hepatitis C
-
Marín Serrano E, Rodríguez Ramos C, Díaz García F, Martín Herrera L, Fernández Gutiérrez del Álamo C, Girón González JA. Hepatocyte growth factor and chronic hepatitis C. Rev Esp Enferm Dig 2010; 102: 365-71.
-
(2010)
Rev Esp Enferm Dig
, vol.102
, pp. 365-371
-
-
Marín Serrano, E.1
Rodríguez Ramos, C.2
Díaz García, F.3
Martín Herrera, L.4
Fernández Gutiérrez del Álamo, C.5
Girón González, J.A.6
|